ImageneBio, Inc.

Imagenebio, Inc.

Biotechnology Healthcare San Diego, CA, United States IMA (NCM)

ImageneBio, Inc., a clinical-stage biotechnology company, develops therapeutics for immunological and inflammatory diseases. The company was formerly known as Ikena Oncology, Inc. and changed its name to ImageneBio, Inc. in July 2025. ImageneBio, Inc. is headquartered in San Diego, California.

Stock Performance (90 Days)

Data through Dec 26, 2025
Price updates on page refresh. Intraday quotes available during market hours (9:30 AM - 4:00 PM EST).

Layoff History

No layoff events recorded for this company.

Recent News

Other Biotechnology Companies

View All →

Frequently Asked Questions

Has ImageneBio, Inc. had layoffs?
No layoff events have been recorded for ImageneBio, Inc. in our database. This could mean the company has not conducted significant layoffs, or any layoffs have not been publicly reported.
What industry is ImageneBio, Inc. in?
ImageneBio, Inc. operates in the Biotechnology industry, within the Healthcare sector.
Is ImageneBio, Inc. a publicly traded company?
Yes, ImageneBio, Inc. is publicly traded under the ticker symbol IMA on the NCM. The company has a market capitalization of approximately $0.06 billion.
Where is ImageneBio, Inc. headquartered?
ImageneBio, Inc. is headquartered in San Diego, CA, United States at 12526 High Bluff Drive, San Diego, CA 92130, United States.

Disclaimer

Data aggregated from public sources including WARN notices, SEC filings, press releases, and market data. While we strive for accuracy, information is provided "as-is" for informational purposes only. Always verify critical information with official company sources.

This information does not constitute investment, financial, legal, or career advice. See our Terms of Service, Privacy Policy, and About page for more information.

Found an error? Report it here.